AIG
VNDA icon

American International Group’s Vanda Pharmaceuticals VNDA Stock Holding History

American International Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,841
Closed -$114K – 2648
2024
Q1 		$114K Sell
27,841
-238
-0.8% -$953 ﹤0.01% 2444
2023
Q4 		$118K Sell
28,079
-114
-0.4% -$460 ﹤0.01% 2466
2023
Q3 		$122K Sell
28,193
-2,190
-7% -$12.2K ﹤0.01% 2400
2023
Q2 		$200K Sell
30,383
-1
-0% -$6 ﹤0.01% 2166
2023
Q1 		$206K Buy
30,384
+138
+0.5% +$970 ﹤0.01% 2090
2022
Q4 		$224K Sell
30,246
-237
-0.8% -$2.31K ﹤0.01% 2080
2022
Q3 		$301K Buy
30,483
+335
+1% +$3.54K ﹤0.01% 1899
2022
Q2 		$329K Sell
30,148
-1,315
-4% -$13.6K ﹤0.01% 1863
2022
Q1 		$356K Sell
31,463
-1,927
-6% -$25.3K ﹤0.01% 1914
2021
Q4 		$524K Sell
33,390
-1,068
-3% -$18.6K ﹤0.01% 1775
2021
Q3 		$591K Sell
34,458
-1,193
-3% -$20.9K ﹤0.01% 1746
2021
Q2 		$767 Sell
35,651
-27,224
-43% -$487K ﹤0.01% 1662
2021
Q1 		$944 Sell
62,875
-3,980
-6% -$64.4K ﹤0.01% 1484
2020
Q4 		$878 Buy
66,855
+29,673
+80% +$357K ﹤0.01% 1457
2020
Q3 		$359K Sell
37,182
-876
-2% -$9.36K ﹤0.01% 1778
2020
Q2 		$435K Buy
38,058
+2,119
+6% +$24K ﹤0.01% 1672
2020
Q1 		$372K Sell
35,939
-1,780
-5% -$22.1K ﹤0.01% 1572
2019
Q4 		$619K Sell
37,719
-1,022
-3% -$15.5K ﹤0.01% 1578
2019
Q3 		$514K Sell
38,741
-402
-1% -$5.6K ﹤0.01% 1640
2019
Q2 		$552K Buy
39,143
+194
+0.5% +$3.09K ﹤0.01% 1646
2019
Q1 		$717K Sell
38,949
-1,032
-3% -$23.5K ﹤0.01% 1509
2018
Q4 		$1.04M Buy
39,981
+5,916
+17% +$139K ﹤0.01% 1242
2018
Q3 		$782K Buy
34,065
+613
+2% +$12.5K ﹤0.01% 1603
2018
Q2 		$637K Buy
33,452
+5,300
+19% +$88.6K ﹤0.01% 1675
2018
Q1 		$474K Sell
28,152
-1,514
-5% -$25.3K ﹤0.01% 1756
2017
Q4 		$451K Buy
29,666
+140
+0.5% +$2.08K ﹤0.01% 1851
2017
Q3 		$529K Buy
29,526
+2,208
+8% +$36.9K ﹤0.01% 1729
2017
Q2 		$445K Buy
27,318
+4,755
+21% +$68.5K ﹤0.01% 1786
2017
Q1 		$316K Buy
22,563
+1,491
+7% +$21.2K ﹤0.01% 1896
2016
Q4 		$336K Sell
21,072
-55
-0.3% -$884 ﹤0.01% 1886
2016
Q3 		$352K Buy
21,127
+32
+0.2% +$431 ﹤0.01% 1815
2016
Q2 		$236K Sell
21,095
-3,386
-14% -$32.8K ﹤0.01% 2026
2016
Q1 		$205K Hold
24,481
– – ﹤0.01% 2771
2015
Q4 		$228K Sell
24,481
-43
-0.2% -$429 ﹤0.01% 2711
2015
Q3 		$277K Buy
24,524
+29
+0.1% +$355 ﹤0.01% 2521
2015
Q2 		$311K Sell
24,495
-666
-3% -$7.18K ﹤0.01% 2612
2015
Q1 		$234K Hold
25,161
– – ﹤0.01% 2814
2014
Q4 		$360K Buy
25,161
+1,789
+8% +$21.2K ﹤0.01% 2415
2014
Q3 		$243K Sell
23,372
-17
-0.1% -$223 ﹤0.01% 2782
2014
Q2 		$378K Buy
23,389
+839
+4% +$11.2K ﹤0.01% 2410
2014
Q1 		$366K Buy
22,550
+541
+2% +$7.69K ﹤0.01% 2326
2013
Q4 		$273K Buy
22,009
+3,007
+16% +$30.2K ﹤0.01% 2498
2013
Q3 		$208K Sell
19,002
-439
-2% -$4.69K ﹤0.01% 2698
2013
Q2 		$157K Buy
+19,441
New +$131K ﹤0.01% 2775

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's VNDA Position: Q2 2024 in Review

American International Group sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 27,841 shares — an estimated $114K sold.

American International Group first reported a position in VNDA in Q2 2013 and held it in 44 quarters. The position peaked at $1.04M in Q4 2018. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.

  • American International Group reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 27,841 Vanda Pharmaceuticals shares in Q2 2024, an estimated $114K.
  • American International Group first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • American International Group's Vanda Pharmaceuticals position peaked at $1.04M in Q4 2018.
  • 148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.